Across TCGA pan-cancer cohorts, LINC00615 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC00615’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where LINC00615 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00615 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

KIRP, LUSC, and KICH are the cancer types where LINC00615 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00615 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	+0.071	.007	6	view →
LUSC	All	All	+0.242	<.001	5	view →
KICH	Male	All	−0.020	.027	2	view →
LUAD	All	All	+0.024	.023	1	view →
KIRC	Male	All	+0.015	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: LINC00615 RNA expression & survival · all LINC00615 data types